Sign in
4

Changes in Ownership

Protalix BioTherapeutics, Inc. Filed Acc 0001178913-14-003121

Director disposed of 1,509,948 shares (other)

  • Director acquired 324,372 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bronfeld Zeev Director 2014-10-02 Other disposition −1,509,948 0 I
Bronfeld Zeev Director 2014-10-02 Other acquisition +324,372 2,162,481 D
Loading xslF345X03/zk1415624.xml…